跳至主要内容
临床试验/NCT02875158
NCT02875158已完成不适用

Modified Settings for Transscleral Cyclophotocoagulation of the Ciliary Body in Glaucoma : A Randomized Controlled Trial

CHU de Quebec-Universite Laval2 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2016年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
44
试验地点
2
主要终点
Intraocular pressure (IOP) evolution

研究概览

简要总结

Transscleral cyclophotocoagulation of the ciliary body is an effective technique to reduce intraocular pressure in case of glaucoma. Due to concerns over complications, the main indications for this second-line treatment are refractory glaucoma medication / surgery and low visual prognosis. The 2000 milliwatts (mW) for 2 seconds settings are used by the majority of researchers and clinicians according to the published literature. Some have proposed using 1250 mW for 4 seconds to improve the use of this medical procedure.

The aim of this study is to determine how different parameters affect the efficacy of the treatment. This is a prospective double-blinded randomized controlled trial comparing two groups, the experimental group using 1250 mW for 4 seconds and the control group using 2000 mW for 2 seconds.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with poorly controlled high pressure glaucoma
  • Cyclophotocoagulation necessary to prevent visual loss
  • Cyclophotocoagulation necessary to prevent or to reduce ocular discomfort

排除标准

  • Patient has already undergone a cyclophotocoagulation or cryotherapy treatment in the same eye for glaucoma
  • Patients receiving concomitant treatment the same day as the intervention
  • Patient not able to follow the prescribed post-operative treatment

结局指标

主要结局

Intraocular pressure (IOP) evolution

时间窗: 1h, 1 month, 6 months, 12 months, 18 months and 24 months post-op

The intraocular pressure is measured to determine the efficacy of treatment during follow-up compared to the baseline IOP.

次要结局

  • Presence of complications(During the intervention, 1 month, 6 months, 12 months, 18 months, 24 months post-op)
  • Use of medication(1 month, 6 months, 12 months, 18 months and 24 months post-op)
  • Retreatment(From the initial treatment up to the last visit (24 months))
  • Visual acuity(1 month, 6 months, 12 months, 18 months and 24 months post-op)

研究者

发起方
CHU de Quebec-Universite Laval
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验